SHANGHAI, Oct. 15 /PRNewswire-Asia/ -- Sundia MediTech, a leading pharmaceutical R&D outsourcing service company in China, announced today that Mr. Charles D. Maher has been appointed Senior Vice President of Sales and Marketing of Sundia.
Prior to joining Sundia, Mr. Maher was Executive Vice President of Global Sales and Marketing of Azopharma Product Development Group, a CRO company in Florida, USA. Azopharma's CRO service scope covers chemical synthesis, analytical, API, preclinical and clinical operations. Mr. Maher was responsible for development and execution of worldwide strategies, and the recruiting and training of business development managers and directors. Mr. Maher previously also worked for Proceryon Biosciences, a CRO company in New York, as Senior Vice President of Business Development for ten years, and for Bio-Rad Laboratories in USA as Director of Sales for eight years.
Mr. Maher has extensive experience in leading many aspects of CRO industry operations, and has accumulated a consistent track record of improving bottom line by growing revenue, reducing costs and maximizing employee productivity through his career.
In his new role in Sundia, Mr. Maher will be responsible for Sundia's business development in global market. Mr. Maher will report directly to Dr. Xiaochuan Wang, Chairman and CEO of Sundia.
"Mr. Maher's past experience is a perfect match to Sundia's business needs. I am very pleased to welcome him to join our team at this very important point of Sundia's development," commented Dr. Xiaochuan Wang. "With the rapid growth of Sundia, we need more experienced and high quality leaders in the company. I have full confidence that our business development team will deliver a outstanding result under the leadership of Mr. Maher."
Mr. Maher had his college education in
|SOURCE Sundia MediTech Company|
Copyright©2009 PR Newswire.
All rights reserved